Transactions are always complex, but carveouts add an extra layer of difficulty. Private equity and strategic buyers need assurances that they can execute carveouts as quickly as possible without putting the business at risk or paying exorbitant fees. That’s where we come in.
Each year, West Monroe delivers over 50 carve-out projects, managing all phases of the carve-out lifecycle – from sell/buy-side due diligence to separation execution. We’ve also been called upon to provide expert testimony and background for high-profile, multi-million-dollar divestiture lawsuits.
Our practitioners bring a unique blend of industry, operational, and technology expertise together to help you tackle carveouts successfully. We manage these from complex diligence through separation value creation, with minimal impact to current business operations.
Clients value our roll-up-our-sleeves execution and practitioner experience with carve-out experience of companies from $30M up to $5B. Technology is often the long pole in the tent in a carve-out transition with IT projects often going over time and over budget. Leverage our best practices from hundreds of carveouts and allow West Monroe to be a one-stop shop that can provide:
Our CORE solution is a pre-packaged selection of service providers and technology platforms to help you create value creation quicker. It provides the greatest probability for a successful carve-out transaction and the quickest means to meet your investment thesis objectives.
When San Francisco biotech company Algenist needed to be quickly up and running as a standalone entity, we were there to accelerate the transition and position the newly independent company for fast growth and implement a new cloud-based ERP in less than five months.
With West Monroe’s strong program management support and guidance in establishing independent operations and technology implementation, OraPharma and its private equity investor completed separation activities ahead of schedule—and saved more than $200,000 in TSA costs in the process.